Cannara Biotech Inc. (TSXV:LOVE)
Canada · Delayed Price · Currency is CAD 1.720
-0.030 (-1.71%)
At close: Feb 2, 2026
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of CAD 164.75 million as of February 3, 2026. Its market cap has increased by 116.37% in one year.
Market Cap
164.75M
Enterprise Value
183.03M
Revenue
112.25M
Ranking
n/a
PE Ratio
14.43
Stock Price
1.72
Market Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 164.75M, a decrease of -22.15%. That is a compound annual growth rate of -3.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 164.75M | -0.32% |
| Dec 31, 2025 | 165.28M | 148.11% |
| Dec 31, 2024 | 66.61M | -10.84% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurora Cannabis | 312.44M |
| Organigram Global | 274.06M |
| TerrAscend | 264.27M |
| Auxly Cannabis Group | 184.55M |
| Ascend Wellness Holdings | 164.57M |
| Cardiol Therapeutics | 142.00M |
| BioSyent | 141.90M |
| HLS Therapeutics | 140.42M |